Latest filing published 23 Sept 2026 for Amphastar Pharmaceuticals, Inc., €90k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
William J. Peters, listed as finance chief, appears in our data through filings on Amphastar Pharmaceuticals, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 19 May 2021 to 21 September 2026, the count stands at 49 filings.
No open-market purchase appears, only 7 sales worth €1.1M. Besides market trades, the filings include 15 share grants and 27 option exercises. 2026 to date brings no purchases and 2 sales.
The record was last updated on 23 September 2026 with an open-market sale (€90k) in Amphastar Pharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 49 declarations